FCR001

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
51	全身性強皮症	1

51. 全身性強皮症

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05098145 (ClinicalTrials.gov)	November 24, 2021	20/10/2021	A Safety and Efficacy Study of FCR001in Adults With Rapidly Progressive Diffuse Cutaneous Systemic S ...	A Single-arm, Multi-center, Open-label Proof of Concept Safety and Efficacy Study of FCR001Cell-base ...	Diffuse Cutaneous Systemic Sclerosis	Biological: FCR001	Talaris Therapeutics Inc.	NULL	Recruiting	18 Years	70 Years	All	18	Phase 1/Phase 2	United States

First Previous1Next Last